155 related articles for article (PubMed ID: 12515928)
21. [Advanced breast cancer: an evaluation of the cost of recurrence].
Bercez C; Lebrun T; Bonneterre ME; Selke B; Lenne X; Bonneterre J
Bull Cancer; 1999 Jun; 86(6):585-90. PubMed ID: 10417432
[TBL] [Abstract][Full Text] [Related]
22. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
[TBL] [Abstract][Full Text] [Related]
23. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
Stäbler W; Wagner B
Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
[TBL] [Abstract][Full Text] [Related]
24. [A study based on national DRG data to evaluate work load and practice relating to cancer patients in not-for-profit hospitals].
Borella L; Peuvrel P; Sauvage M; Maraninchi D; Philip T
Rev Epidemiol Sante Publique; 2000 Jan; 48(1):53-70. PubMed ID: 10740085
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
[TBL] [Abstract][Full Text] [Related]
26. An economic model of one-level lumbar arthroplasty versus fusion.
Guyer RD; Tromanhauser SG; Regan JJ
Spine J; 2007; 7(5):558-62. PubMed ID: 17588819
[TBL] [Abstract][Full Text] [Related]
27. Financial modeling for global pricing: the NCCN breast cancer prototype. National Comprehensive Cancer Network.
Perkel SJ
Oncology (Williston Park); 1999 May; 13(5A):73-4. PubMed ID: 10370923
[TBL] [Abstract][Full Text] [Related]
28. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
29. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
30. Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups.
Lauzier S; Maunsell E; De Koninck M; Drolet M; Hébert-Croteau N; Robert J
Psychooncology; 2005 May; 14(5):351-60. PubMed ID: 15386763
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
32. Incidence and costs of injuries in The Netherlands.
Meerding WJ; Mulder S; van Beeck EF
Eur J Public Health; 2006 Jun; 16(3):272-8. PubMed ID: 16476683
[TBL] [Abstract][Full Text] [Related]
33. Cost comparison study of two different follow-up protocols after surgery for oesophageal cancer.
Polinder S; Verschuur EM; Siersema PD; Kuipers EJ; Steyerberg EW
Eur J Cancer; 2009 Aug; 45(12):2110-5. PubMed ID: 19398325
[TBL] [Abstract][Full Text] [Related]
34. [A method to determine hospital costs associated with nosocomial infections].
Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
Lundkvist J; Ekman M; Ericsson SR; Isacsson U; Jönsson B; Glimelius B
Radiother Oncol; 2005 May; 75(2):179-85. PubMed ID: 15885828
[TBL] [Abstract][Full Text] [Related]
36. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer.
Suh WW; Pierce LJ; Vicini FA; Hayman JA
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):790-6. PubMed ID: 15936561
[TBL] [Abstract][Full Text] [Related]
37. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
[TBL] [Abstract][Full Text] [Related]
38. [Adjuvant treatment of cancer of the breast: cost assessment of the protocol used].
Selke B; Bercez C; Lenne X; Bonneterre ME; Lebrun T; Bonneterre J
Bull Cancer; 1998 Nov; 85(11):961-6. PubMed ID: 9951423
[TBL] [Abstract][Full Text] [Related]
39. Burden of breast cancer with brain metastasis: a French national hospital database analysis.
Benjamin L; Cotté FE; Mercier F; Vainchtock A; Vidal-Trécan G; Durand-Zaleski I
J Med Econ; 2012; 15(3):493-9. PubMed ID: 22304337
[TBL] [Abstract][Full Text] [Related]
40. Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer.
De Rosa L; Lalle M; Pandolfi A; Pescador L
Bone Marrow Transplant; 2001 May; 27(10):1031-5. PubMed ID: 11438817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
